{"id":381150,"date":"2020-11-13T17:03:36","date_gmt":"2020-11-13T22:03:36","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=381150"},"modified":"2020-11-13T17:03:36","modified_gmt":"2020-11-13T22:03:36","slug":"top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/","title":{"rendered":"TOP RANKED ROSEN LAW FIRM Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm – BIIB"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n NEW YORK<\/span>, Nov. 13, 2020<\/span> \/PRNewswire\/ — Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Biogen Inc. (NASDAQ: BIIB), between October 22, 2019<\/span> and November 6, 2020<\/span>, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Biogen investors under the federal securities laws.<\/p>\n

\n

\n
\n \"Rosen
\n <\/a>\n <\/p>\n<\/p><\/div>\n

To join the Biogen class action, go to http:\/\/www.rosenlegal.com\/cases-register-1981.html<\/a>\u00a0or call Phillip Kim, Esq.<\/span> toll-free at 866-767-3653 or email pkim@rosenlegal.com<\/a>\u00a0or cases@rosenlegal.com<\/a>\u00a0for information on the class action.<\/p>\n

According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: (1) the larger dataset did not provide necessary data regarding aducanumab’s effectiveness; (2) the EMERGE study did not and would not provide necessary data regarding aducanumab’s effectiveness; (3) the PRIME study did not and would not provide necessary data regarding aducanumab’s effectiveness; (4) the data provided by the Company to the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee did not support finding efficacy of aducanumab; and (5) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and\/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.<\/p>\n

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 12, 2021<\/span><\/b>. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http:\/\/www.rosenlegal.com\/cases-register-1981.html<\/a>\u00a0or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq.<\/span> of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com<\/a> or cases@rosenlegal.com<\/a>.<\/p>\n

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.<\/p>\n

Follow us for updates on LinkedIn: https:\/\/www.linkedin.com\/company\/the-rosen-law-firm<\/a> or on Twitter: https:\/\/twitter.com\/rosen_firm<\/a> or on Facebook: https:\/\/www.facebook.com\/rosenlawfirm<\/a>. <\/p>\n

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome. <\/p>\n

Contact Information:<\/p>\n

\u00a0\u00a0\u00a0\u00a0\u00a0 Laurence Rosen, Esq.<\/span>\u00a0
\u00a0\u00a0\u00a0\u00a0\u00a0 Phillip Kim, Esq.<\/span>\u00a0
\u00a0\u00a0\u00a0\u00a0\u00a0 The Rosen Law Firm, P.A.\u00a0
\u00a0\u00a0\u00a0\u00a0\u00a0 275 Madison Avenue, 40th<\/sup> Floor\u00a0
\u00a0\u00a0\u00a0\u00a0\u00a0 New York<\/span>, NY\u00a0 10016\u00a0
\u00a0\u00a0\u00a0\u00a0\u00a0 Tel: (212) 686-1060\u00a0
\u00a0\u00a0\u00a0\u00a0\u00a0 Toll Free: (866) 767-3653\u00a0
\u00a0\u00a0\u00a0\u00a0\u00a0 Fax: (212) 202-3827\u00a0
\u00a0\u00a0\u00a0\u00a0\u00a0 lrosen@rosenlegal.com
<\/a>\u00a0\u00a0\u00a0\u00a0\u00a0 pkim@rosenlegal.com
<\/a>\u00a0\u00a0\u00a0\u00a0\u00a0 cases@rosenlegal.com<\/a>\u00a0\u00a0
\u00a0\u00a0\u00a0\u00a0\u00a0 www.rosenlegal.com<\/a>\u00a0 <\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm–biib-301173004.html<\/a><\/p>\n

SOURCE Rosen Law Firm, P.A.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire NEW YORK, Nov. 13, 2020 \/PRNewswire\/ — Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Biogen Inc. (NASDAQ: BIIB), between October 22, 2019 and November 6, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Biogen investors under the federal securities laws. To join the Biogen class action, go to http:\/\/www.rosenlegal.com\/cases-register-1981.html\u00a0or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com\u00a0or cases@rosenlegal.com\u00a0for information on the class action. According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: (1) the larger dataset did not provide necessary data regarding aducanumab’s effectiveness; … <\/p>\n

Continue reading “TOP RANKED ROSEN LAW FIRM Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm – BIIB”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-381150","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTOP RANKED ROSEN LAW FIRM Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm - BIIB - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TOP RANKED ROSEN LAW FIRM Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm - BIIB - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, Nov. 13, 2020 \/PRNewswire\/ — Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Biogen Inc. (NASDAQ: BIIB), between October 22, 2019 and November 6, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Biogen investors under the federal securities laws. To join the Biogen class action, go to http:\/\/www.rosenlegal.com\/cases-register-1981.html\u00a0or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com\u00a0or cases@rosenlegal.com\u00a0for information on the class action. According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: (1) the larger dataset did not provide necessary data regarding aducanumab’s effectiveness; … Continue reading "TOP RANKED ROSEN LAW FIRM Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm – BIIB"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-13T22:03:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/405060\/Rosen_Law_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TOP RANKED ROSEN LAW FIRM Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm – BIIB\",\"datePublished\":\"2020-11-13T22:03:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\\\/\"},\"wordCount\":597,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/405060\\\/Rosen_Law_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\\\/\",\"name\":\"TOP RANKED ROSEN LAW FIRM Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm - BIIB - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/405060\\\/Rosen_Law_Logo.jpg\",\"datePublished\":\"2020-11-13T22:03:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/405060\\\/Rosen_Law_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/405060\\\/Rosen_Law_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TOP RANKED ROSEN LAW FIRM Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm – BIIB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TOP RANKED ROSEN LAW FIRM Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm - BIIB - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/","og_locale":"en_US","og_type":"article","og_title":"TOP RANKED ROSEN LAW FIRM Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm - BIIB - Market Newsdesk","og_description":"PR Newswire NEW YORK, Nov. 13, 2020 \/PRNewswire\/ — Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Biogen Inc. (NASDAQ: BIIB), between October 22, 2019 and November 6, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Biogen investors under the federal securities laws. To join the Biogen class action, go to http:\/\/www.rosenlegal.com\/cases-register-1981.html\u00a0or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com\u00a0or cases@rosenlegal.com\u00a0for information on the class action. According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: (1) the larger dataset did not provide necessary data regarding aducanumab’s effectiveness; … Continue reading \"TOP RANKED ROSEN LAW FIRM Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm – BIIB\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-13T22:03:36+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/405060\/Rosen_Law_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TOP RANKED ROSEN LAW FIRM Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm – BIIB","datePublished":"2020-11-13T22:03:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/"},"wordCount":597,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/405060\/Rosen_Law_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/","name":"TOP RANKED ROSEN LAW FIRM Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm - BIIB - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/405060\/Rosen_Law_Logo.jpg","datePublished":"2020-11-13T22:03:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/405060\/Rosen_Law_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/405060\/Rosen_Law_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/top-ranked-rosen-law-firm-files-first-securities-class-action-lawsuit-against-biogen-inc-encourages-investors-with-losses-in-excess-of-500k-to-contact-the-firm-biib\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TOP RANKED ROSEN LAW FIRM Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm – BIIB"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=381150"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381150\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=381150"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=381150"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=381150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}